New York, January 04, 2019: The scope of the report includes a detailed study of global and regional markets for Global Interventional Cardiology & Peripheral Vascular Devices Market with the reasons given for variations in the growth of the industry in certain regions.
Interventional cardiology offers with catheter-based totally technologies for the remedy of structural heart sicknesses. The technique entails the insertion of a tool into the femoral artery or any big peripheral artery or vein, and cannulating the heart below x-ray visualization commonly called fluoroscopy. Further, severa interventional gadgets are used to deal with peripheral vascular issues that have an effect on the circulatory machine, and may lead to plaque constructed-up within the arteries of limbs. Some of the interventional devices used within the market include balloons, catheters, guide wires, stents, and filters.
The major driving factors of Global Interventional Cardiology & Peripheral Vascular Devices Market are as follows:
• Expansion in geriatric population
• Technical advancements in cardiology devices
• Enhance in prevalence of chronic diseases
• Development of healthcare infrastructure in developing nations
• Enhance in patient awareness
• Growth of minimally invasive procedures
The restraining factors of Global Interventional Cardiology & Peripheral Vascular Devices Market are as follows:
• Strict approval procedure for interventional cardiology & peripheral vascular devices
• High treatment rate of a few devices
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Edwards Lifesciences Corporation, ABIOMED, Inc., AngioDynamics, Inc., Becton, Dickinson & Co., Lepu Medical Technology (Beijing) Co. Ltd., Baxter International Inc., Siemens AG, 3M Company, Biotronik SE & Co. KG, Smith & Nephew plc, Sahajananad Medical Technologies Ltd., HeartWare International, Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Global Interventional Cardiology & Peripheral Vascular Devices Market is expected to exceed more than US$ 25.3 billion by 2022 and will grow at a CAGR of more than 7% in the given forecast period.
The Global Interventional Cardiology & Peripheral Vascular Devices Market has been segmented as below:
The Global Interventional Cardiology & Peripheral Vascular Devices Market is Segmented on the lines of Product Analysis and Regional Analysis.
By Product Analysis this market is segmented on the basis of Angioplasty Balloons its covers Old/Normal Balloons, Cutting and Scoring Balloons & Drug-eluting Balloons. Angioplasty Catheters its covers Angiography Catheters & Guiding Catheters. Angioplasty Stents its covers Drug-eluting Stents, Bare Metal Stents & Bioabsorbable Stents. Endovascular Aneurysm Repair Stent Grafts its covers Abdominal Aortic Aneurysm & Thoracic Aortic Aneurysm. Plaque Modification Devices its covers Thrombectomy Devices & Atherectomy Devices. Inferior Vena Cava (IVC) Filters its covers Retrievable Filters & Permanent Filters. Hemodynamic Flow Alteration Devices its covers Embolic Protection Devices & Chronic Total Occlusion Devices. Accessories its covers Vascular Closure Devices, Introducer Sheaths, Guidewires & Balloon Inflation Devices.
By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
This report provides:
1) An overview of the global market for interventional cardiology & peripheral vascular devices and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for interventional cardiology & peripheral vascular devices.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/interventional-cardiology-and-peripheral-vascular-devices-market
Table of Contents
2 Research Methodology
2.1 Interventional Cardiology Market Size Estimation
2.2 Interventional Cardiology Market Breakdown and Data Triangulation
2.3 Interventional Cardiology Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Angioplasty Market, By Procedure
7 Angioplasty Balloons Market, By Type
8 Angioplasty Stents Market, By Type
9 Catheters Market, By Type
10 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market, By Type
11 Inferior Vena Cava (IVC) Filters Market, By Type
12 Plaque Modification Devices Market, By Type
13 Hemodynamic Flow Alteration Devices Market, By Type
14 Interventional Cardiology and Peripheral Vascular Device Accessories Market, By Type
15 Interventional Cardiology and Peripheral Vascular Devices Market, By Region
16 Competitive Landscape
17 Company Profile
17.2 Medtronic PLC
17.3 Boston Scientific Corporation
17.4 Abbott Laboratories
17.5 Cordis Corporation (A Subsidiary of Johnson & Johnson Services, Inc.)
17.6 Accessclosure, Inc. (A Subsidiary of Cardinal Health, Inc.)
17.7 B. Braun Melsungen AG
17.8 Biosensors International Group Ltd.
17.9 C.R. Bard, Inc.
17.10 St. Jude Medical, Inc.
17.11 Terumo Corporation
Other Related Market Research Reports:
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
The post Interventional Cardiology & Peripheral Vascular Devices Market Forecast to Touch US$ 25 Billion by 2024 appeared first on Herald Keeper.